SCHEMBL5331769

SCHEMBL5331769

CCOC(=O)COc1cc(C(=O)O)n(C)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.45
KDM4E B2RXH2 6/20 0.44
ALDH1A1 P00352 4/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HSD17B10 Q99714 3/20 0.43
HPGD P15428 3/20 0.43
MAPT P10636 2/20 0.43
TP53 P04637 1/20 0.43
GRN P28799 1/20 0.42
SORT1 Q99523 1/20 0.42
CASP3 P42574 1/20 0.40
CASP7 P55210 1/20 0.40
CASP9 P55211 1/20 0.40
GAA P10253 2/20 0.40
TBXAS1 P24557 1/20 0.39
NPSR1 Q6W5P4 2/20 0.38
KLK7 P49862 1/20 0.38
LMNA P02545 1/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2522003 0.85 KDM4E (0.49) PKMKDM4EALDH1A1SMN1; SMN2HSD17B10
SCHEMBL4759203 0.83 PKM (0.61) PKMKDM4EALDH1A1GRNSORT1
SCHEMBL24425293 0.79 ALDH1A1 (0.51) KDM4EALDH1A1SMN1; SMN2HSD17B10HPGD
SCHEMBL20797378 0.78 PKM (0.71) PKMKDM4EALDH1A1SMN1; SMN2HSD17B10
SCHEMBL17473467 0.77 KDM4E (0.47) PKMKDM4EALDH1A1SMN1; SMN2HSD17B10
SCHEMBL27114081 0.77 KDM4E (0.44) PKMKDM4EALDH1A1SMN1; SMN2HSD17B10
SCHEMBL24408948 0.77 KDM4E (0.44) KDM4EALDH1A1SMN1; SMN2HSD17B10HPGD
SCHEMBL21607915 0.76 LMNA (0.52) KDM4EALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL14292543 0.76 KDM4E (0.46) PKMKDM4EALDH1A1GRNSORT1
SCHEMBL7703521 0.76 LMNA (0.52) KDM4EALDH1A1SMN1; SMN2MAPTGRN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7205403-B2 8-Heteroaryl xanthine adenosine A2B receptor antagonists KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC. (US) 2007-04-17 US disclosed